ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,884.11
-1.49%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.666
0.33%
Brent Oil
83.735
-0.72%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) ニュース

VRDN

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VRDN
日付受信時刻ニュースソース見出しコード企業名
2022/11/0821 : 00GlobeNewswire Inc.Viridian Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 14, 2022NASDAQ:VRDNViridian Therapeutics Inc
2022/10/2715 : 05TipRanksSVB Securities Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/10/2620 : 05TipRanksWedbush Sticks to Its Buy Rating for Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/10/2303 : 04GlobeNewswire Inc.Viridian Presents Positive Clinical Data from Ongoing VRDN-001 Phase 1/2 Trial in Active Thyroid Eye Disease (TED) Patients During Late-Breaking Presentations at the American Thyroid Association (ATA) 91st Annual MeetingNASDAQ:VRDNViridian Therapeutics Inc
2022/10/1221 : 12GlobeNewswire Inc.Viridian Therapeutics Announces Presentations at the American Thyroid Association 91st Annual MeetingNASDAQ:VRDNViridian Therapeutics Inc
2022/09/0221 : 00GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/2605 : 03GlobeNewswire Inc.Viridian Therapeutics Announces Exercise in Full and Closing of Underwriters’ Option to Purchase Additional Shares in Public OfferingNASDAQ:VRDNViridian Therapeutics Inc
2022/08/2005 : 35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1911 : 20TipRanksAnalysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pear Therapeutics (PEAR)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1905 : 42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1819 : 31TipRanksAnalysts’ Top Healthcare Picks: Viridian Therapeutics (VRDN), Springworks Therapeutics (SWTX)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1719 : 00GlobeNewswire Inc.Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred StockNASDAQ:VRDNViridian Therapeutics Inc
2022/08/1620 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1619 : 07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1617 : 46TipRanksViridian Therapeutics (VRDN) Receives a Buy from SVB SecuritiesNASDAQ:VRDNViridian Therapeutics Inc
2022/08/1605 : 21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1605 : 01GlobeNewswire Inc.Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred StockNASDAQ:VRDNViridian Therapeutics Inc
2022/08/1603 : 35TipRanksLadenburg Thalmann & Co. Sticks to Its Buy Rating for Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1602 : 25TipRanksViridian Therapeutics (VRDN) Gets a Buy from JMP SecuritiesNASDAQ:VRDNViridian Therapeutics Inc
2022/08/1602 : 15TipRanksViridian Therapeutics (VRDN) Receives a Buy from WedbushNASDAQ:VRDNViridian Therapeutics Inc
2022/08/1601 : 40TipRanksAnalysts Offer Insights on Healthcare Companies: Azenta (AZTA), AKOUOS (AKUS) and Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1520 : 27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/1520 : 02GlobeNewswire Inc.Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
2022/08/1519 : 59GlobeNewswire Inc.Viridian Announces Positive Initial Clinical Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)NASDAQ:VRDNViridian Therapeutics Inc
2022/08/0821 : 00GlobeNewswire Inc.Viridian Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call on August 15, 2022NASDAQ:VRDNViridian Therapeutics Inc
2022/08/0521 : 00GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
2022/07/0821 : 00GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
2022/06/2320 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2022/06/2320 : 00GlobeNewswire Inc.Viridian Therapeutics Appoints Carrie Melvin as Chief Operating OfficerNASDAQ:VRDNViridian Therapeutics Inc
2022/06/1020 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VRDN

最近閲覧した銘柄

CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
SPI
SP500
S&P 500
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有